psalexa
logo

Foot and Ankle Devices Market

Global Foot and Ankle Devices Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS10450
Available Format:

Chapter 1. Research Background

1.1. Research Objectives

1.2. Market Definition

1.3. Research Scope

1.3.1. Market Segmentation by Product

1.3.2. Market Segmentation by Cause of Injury

1.3.3. Market Segmentation by End User

1.3.4. Market Segmentation by Geography

1.3.5. Analysis Period

1.3.6. Market Data Reporting Unit

1.3.6.1. Value

1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.2. Primary Research

2.2.1. Breakdown of Primary Research Respondents

2.2.1.1. By region

2.2.1.2. By industry participant

2.2.1.3. By company type

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Definition of Market Segments

4.1.1. By Product

4.1.1.1. Orthopedic implants and devices

4.1.1.1.1. Fixation devices

4.1.1.1.1.1. Internal fixation devices

4.1.1.1.1.1.1. Screws

4.1.1.1.1.1.2. Plates

4.1.1.1.1.1.3. Wires & pins

4.1.1.1.1.1.4. Fusion nails

4.1.1.1.1.2. External fixation devices

4.1.1.1.1.2.1. Unilateral fixators

4.1.1.1.1.2.2. Ring ankle fixators

4.1.1.1.1.2.3. Hybrid fixators

4.1.1.1.2. Joint implants

4.1.1.1.2.1. Ankle implants (ankle replacement devices)

4.1.1.1.2.2. Subtalar joint implants/subtalar joint reconstruction devices

4.1.1.1.2.3. Phalangeal implants

4.1.1.1.3. Soft-Tissue orthopedic devices

4.1.1.1.3.1. Artificial tendons & ligaments

4.1.1.1.3.2. Musculoskeletal reinforcement devices

4.1.1.2. Prostheses

4.1.1.2.1. Solid ankle cushion heel (SACH) foot

4.1.1.2.2. Single-axial prostheses

4.1.1.2.3. Multiaxial prostheses

4.1.1.2.4. Dynamic response/energy-storing prostheses

4.1.1.2.5. Microprocessor-controlled (MPC) prostheses

4.1.1.3. Bracing and support devices

4.1.1.3.1. Soft bracing

4.1.1.3.2. Hinged braces

4.1.2. By Cause of Injury

4.1.2.1. Trauma

4.1.2.2. Diabetes

4.1.2.3. Neurological disorders

4.1.2.4. Others 

4.1.3. By End User

4.1.3.1. Hospitals

4.1.3.2. Ambulatory service centers (ASCs)

4.1.3.3. Others

4.2. Market Dynamics

4.2.1. Trends

4.2.2. Drivers

4.2.2.1. Impact analysis of drivers on market forecast

4.2.3. Restraints

4.2.3.1. Impact analysis of restraints on market forecast

4.2.4. Opportunities

4.3. Porter’s Five Forces Analysis

Chapter 5. Global Market Size and Forecast

5.1. By Product

5.2. By Cause of Injury

5.3. By End User

5.4. By Region

Chapter 6. North America Market Size and Forecast

6.1. By Product

6.2. By Cause of Injury

6.3. By End User

6.4. By Country – U.S., Canada

Chapter 7. Europe Market Size and Forecast

7.1. By Product

7.2. By Cause of Injury

7.3. By End User

7.4. By Country – Germany, U.K., France, Italy, Spain and Rest of Europe

Chapter 8. Asia-Pacific Market Size and Forecast

8.1. By Product

8.2. By Cause of Injury

8.3. By End User                                                   

8.4. By Country – Japan, China, Australia, India and Rest of Asia-Pacific

Chapter 9. Latin America Market Size and Forecast

9.1. By Product

9.2. By Cause of Injury

9.3. By End User

9.4. By Country – Brazil, Mexico and Rest of Latin America

Chapter 10. Middle East and Africa Market Size and Forecast

10.1. By Product

10.2. By Cause of Injury

10.3. By End User

Chapter 11. Competitive Landscape

11.1. Market Share Analysis of Key Players

11.2. Competitive Analysis of Key Players

11.3. Global Strategic Developments of Key Players

Chapter 12. Company Profiles

12.1. Stryker Corporation

12.1.1. Business Overview

12.1.2. Product and Service Offerings

12.1.3. Key Financial Summary

12.1.4. Strategic Growth Plans

12.2. Arthrex, Inc.

12.2.1. Business Overview

12.2.2. Product and Service Offerings

12.2.3. Key Financial Summary

12.2.4. Strategic Growth Plans

12.3. Zimmer Biomet Holdings, Inc.

12.3.1. Business Overview

12.3.2. Product and Service Offerings

12.3.3. Key Financial Summary

12.3.4. Strategic Growth Plans

12.4. Smith & Nephew PLC.

12.4.1. Business Overview

12.4.2. Product and Service Offerings

12.4.3. Key Financial Summary

12.4.4. Strategic Growth Plans

12.5. Wright Medical Group N.V.

12.5.1. Business Overview

12.5.2. Product and Service Offerings

12.5.3. Key Financial Summary

12.5.4. Strategic Growth Plans

12.6. Integra Lifesciences Holdings Corporation

12.6.1. Business Overview

12.6.2. Product and Service Offerings

12.6.3. Key Financial Summary

12.6.4. Strategic Growth Plans

12.7. Össur

12.7.1. Business Overview

12.7.2. Product and Service Offerings

12.7.3. Key Financial Summary

12.7.4. Strategic Growth Plans

12.8. Extremity Medical, LLC

12.8.1. Business Overview

12.8.2. Product and Service Offerings

12.8.3. Key Financial Summary

12.8.4. Strategic Growth Plans

12.9. DePuy Orthopaedics (Johnson & Johnson)

12.9.1. Business Overview

12.9.2. Product and Service Offerings

12.9.3. Key Financial Summary

12.9.4. Strategic Growth Plans

12.10. Orthofix, Inc

12.10.1. Business Overview

12.10.2. Product and Service Offerings

12.10.3. Key Financial Summary

12.10.4. Strategic Growth Plans

*Note: Key financial summary and strategic growth plans will be provided on best effort basis and is subject to availability of information during primary and secondary research.

Chapter 13. Appendix

13.1. Abbreviations

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry